[1] Zhang S, Wang J, Yuan Q, et al .Clinical characteristics and risk factors of sporadic Hepatitis E in central China. Virol J, 2011, 8:152. [2] Park SB. Hepatitis E vaccine debuts. Nature, 2012, 491:21-22 [3] 陈奕娟,秦淑文,缪梓萍.戊型肝炎流行病学研究新进展. 预防医学,2016,28:1014-1018. [4] Wedemeyer H, Rybczynska J, Pischke S, et al. Immunopathogenesis of hepatitis E virus infection. Semin Liver Dis, 2013, 33:71-78. [5] Kamar N, Dalton HR, Abravanel F, et al. Hepatitis E virus infection . Clin Microbiol Rev, 2014, 27:116-138. [6] 中华人民共和国卫生部.戊型病毒性肝炎诊断标准(WS-2008)[EB/OL].[2020-09-02]. [7] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J].临床肝胆病杂志,2019,35:38-44. [8] Cornelia A, Ana A, Sally A. et al Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15. J Clin Virol, 2016, 82. [9] 孙校金,王富珍,郑徽,等.中国2004-2015年不同预防接种阶段甲型肝炎和戊型肝炎流行病学特征比较.中华流行病学杂志,2018,39:1351-1355. [10] Dalton HR, Stableforth W, Thurairajah P, et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease . Eur J Gastroenterol Hepatol, 2008, 20:784-790. [11] 耿家宝,王敏,刘倩楠,等.我国东部地区戊型肝炎的流行病学特点.肝脏,2016,21:48-51. [12] Kammar N, Bendall R, Legrand-Abravancel F, et al. Hepatitis E . Lancet, 2012, 379: 2477-2488. [13] Schiff ER, Sorrell MF, Maddrey WC. 希夫肝脏病学.黄志强译.北京:化学工业出版社,2006,783. [14] 刘玉,梅雪,张宇一,等.急性戊型肝炎严重黄疸患者的临床特征及危险因素分析.临床肝胆病杂志,2021,37:565-569. |